2024-03-19 |
2024-03-15 |
PS
Planned sale
|
Gunther Scott
SVP, Quality & Reg. Affairs
Officer
|
387
-1.3%
56.20
21,749
USD
|
387
-1.3%
|
56.20
|
21,749
USD
|
|
2023-09-05 |
2023-08-31 |
B
Purchase
|
Ryan Michelle R
Non-Executive Director
|
1,000
+102.1%
49.98
49,980
USD
|
1,000
+102.1%
|
49.98
|
49,980
USD
|
|
2023-09-01 |
2023-08-30 |
B
Purchase
|
GREISCH JOHN J
Executive Chair
Executive Director
|
21,000
+161.5%
50.24
1,055,040
USD
|
21,000
+161.5%
|
50.24
|
1,055,040
USD
|
|
2023-08-25 |
2023-08-24 |
S
Sale
|
Arnold Jonathan
SVP, CCO & Div. Head BioP Del.
Officer
|
87
-0.2%
44.87
3,904
USD
|
87
-0.2%
|
44.87
|
3,904
USD
|
|
2023-08-25 |
2023-08-24 |
PS
Planned sale
|
Hopson Ricky
Pres. Clinical Dev Supply Div
Officer
|
276
-1.2%
44.56
12,299
USD
|
276
-1.2%
|
44.56
|
12,299
USD
|
|
2023-08-25 |
2023-08-24 |
S
Sale
|
Gennadios Aristippos
Group Pres. Pharma & Consumer
Officer
|
396
-0.4%
44.49
17,618
USD
|
396
-0.4%
|
44.49
|
17,618
USD
|
|
2023-08-25 |
2023-08-24 |
S
Sale
|
Maselli Alessandro
President & CEO
Executive Director
|
101
-0.1%
45.15
4,560
USD
|
101
-0.1%
|
45.15
|
4,560
USD
|
|
2023-08-25 |
2023-08-24 |
S
Sale
|
Maselli Alessandro
President & CEO
Executive Director
|
1,970
-2.2%
44.51
87,685
USD
|
1,970
-2.2%
|
44.51
|
87,685
USD
|
|
2023-08-25 |
2023-08-24 |
S
Sale
|
Lickfold Charles
SVP, CIO
Officer
|
190
-1.6%
44.72
8,497
USD
|
190
-1.6%
|
44.72
|
8,497
USD
|
|
2023-08-25 |
2023-08-24 |
S
Sale
|
Hawkeswood Thomas W
Pres. Pharma Prod Delivery Div
Officer
|
147
-1.9%
44.72
6,574
USD
|
147
-1.9%
|
44.72
|
6,574
USD
|
|
2023-08-25 |
2023-08-24 |
S
Sale
|
Carletti Lorenzo
SVP Global Ops Ph & Cons Hlth
Officer
|
216
-2.4%
44.71
9,657
USD
|
216
-2.4%
|
44.71
|
9,657
USD
|
|
2023-08-25 |
2023-08-24 |
S
Sale
|
Grippo Michael J
SVP, Strategy & Corp. Dev.
Officer
|
390
-1.6%
44.50
17,355
USD
|
390
-1.6%
|
44.50
|
17,355
USD
|
|
2023-08-25 |
2023-08-24 |
S
Sale
|
Gunther Scott
SVP, Quality & Reg. Affairs
Officer
|
269
-0.9%
44.57
11,989
USD
|
269
-0.9%
|
44.57
|
11,989
USD
|
|
2023-08-25 |
2023-08-24 |
S
Sale
|
Hunt Patricia
Pres. Consumer Health Div
Officer
|
106
-0.9%
44.77
4,746
USD
|
106
-0.9%
|
44.77
|
4,746
USD
|
|
2023-08-25 |
2023-08-24 |
S
Sale
|
Pravda Ricardo
Chief Transformation Officer
Officer
|
379
-1.2%
44.47
16,854
USD
|
379
-1.2%
|
44.47
|
16,854
USD
|
|
2023-08-25 |
2023-08-24 |
PS
Planned sale
|
Fasman Steven L
EVP & Chief Admin Officer
Officer
|
817
-1.1%
44.65
36,479
USD
|
817
-1.1%
|
44.65
|
36,479
USD
|
|
2023-08-03 |
2023-08-01 |
S
Sale
|
Fasman Steven L
EVP & Chief Admin Officer
Officer
|
524
-0.9%
47.76
25,026
USD
|
524
-0.9%
|
47.76
|
25,026
USD
|
|
2023-08-03 |
2023-08-01 |
S
Sale
|
Fasman Steven L
EVP & Chief Admin Officer
Officer
|
1,113
-1.8%
46.72
51,999
USD
|
1,113
-1.8%
|
46.72
|
51,999
USD
|
|
2023-08-03 |
2023-08-01 |
S
Sale
|
Lickfold Charles
SVP, CIO
Officer
|
135
-2.4%
47.90
6,467
USD
|
135
-2.4%
|
47.90
|
6,467
USD
|
|
2023-08-03 |
2023-08-01 |
S
Sale
|
Arnold Jonathan
SVP, CCO & Div. Head BioP Del.
Officer
|
62
-0.1%
47.80
2,964
USD
|
62
-0.1%
|
47.80
|
2,964
USD
|
|
2023-08-03 |
2023-08-01 |
S
Sale
|
Hunt Patricia
Pres. Consumer Health Div
Officer
|
161
-1.7%
47.95
7,720
USD
|
161
-1.7%
|
47.95
|
7,720
USD
|
|
2023-08-03 |
2023-08-01 |
S
Sale
|
Pravda Ricardo
Chief Transformation Officer
Officer
|
222
-1.1%
47.78
10,607
USD
|
222
-1.1%
|
47.78
|
10,607
USD
|
|
2023-08-03 |
2023-08-01 |
S
Sale
|
Pravda Ricardo
Chief Transformation Officer
Officer
|
47
-0.2%
46.50
2,186
USD
|
47
-0.2%
|
46.50
|
2,186
USD
|
|
2023-08-03 |
2023-08-01 |
S
Sale
|
Gennadios Aristippos
Group Pres. Pharma & Consumer
Officer
|
220
-0.3%
47.87
10,531
USD
|
220
-0.3%
|
47.87
|
10,531
USD
|
|
2023-08-03 |
2023-08-01 |
S
Sale
|
Gennadios Aristippos
Group Pres. Pharma & Consumer
Officer
|
61
-0.1%
46.58
2,841
USD
|
61
-0.1%
|
46.58
|
2,841
USD
|
|
2023-08-03 |
2023-08-01 |
S
Sale
|
Hawkeswood Thomas W
Pres. Pharma Prod Delivery Div
Officer
|
258
-4.8%
47.97
12,376
USD
|
258
-4.8%
|
47.97
|
12,376
USD
|
|
2023-08-03 |
2023-08-01 |
S
Sale
|
Gunther Scott
SVP, Quality & Reg. Affairs
Officer
|
190
-0.8%
47.90
9,101
USD
|
190
-0.8%
|
47.90
|
9,101
USD
|
|
2023-08-03 |
2023-08-01 |
S
Sale
|
Hopson Ricky
Pres. Clinical Dev Supply Div
Officer
|
195
-1.2%
47.86
9,333
USD
|
195
-1.2%
|
47.86
|
9,333
USD
|
|
2023-08-03 |
2023-08-01 |
S
Sale
|
Carletti Lorenzo
SVP Global Ops Ph & Cons Hlth
Officer
|
383
-7.7%
47.77
18,296
USD
|
383
-7.7%
|
47.77
|
18,296
USD
|
|
2023-08-03 |
2023-08-01 |
S
Sale
|
Grippo Michael J
SVP, Strategy & Corp. Dev.
Officer
|
241
-1.4%
47.88
11,539
USD
|
241
-1.4%
|
47.88
|
11,539
USD
|
|
2023-08-03 |
2023-08-01 |
S
Sale
|
Grippo Michael J
SVP, Strategy & Corp. Dev.
Officer
|
35
-0.2%
46.64
1,632
USD
|
35
-0.2%
|
46.64
|
1,632
USD
|
|
2023-08-03 |
2023-08-01 |
S
Sale
|
Maselli Alessandro
President & CEO
Executive Director
|
606
-0.7%
47.75
28,937
USD
|
606
-0.7%
|
47.75
|
28,937
USD
|
|
2023-08-03 |
2023-08-01 |
S
Sale
|
Maselli Alessandro
President & CEO
Executive Director
|
879
-1.0%
46.71
41,058
USD
|
879
-1.0%
|
46.71
|
41,058
USD
|
|
2023-05-03 |
2023-05-01 |
S
Sale
|
Boerman Manja
Pres. BioModalities Division
Officer
|
1,446
-9.1%
49.86
72,098
USD
|
1,446
-9.1%
|
49.86
|
72,098
USD
|
|
2023-05-03 |
2023-05-01 |
S
Sale
|
Gargiulo Mario
SVP, Ops, Biologics Europe
Officer
|
678
-10.7%
49.86
33,805
USD
|
678
-10.7%
|
49.86
|
33,805
USD
|
|
2023-01-25 |
2023-01-23 |
S
Sale
|
Hopson Ricky
Pres. Clinical Dev Supply Div
Officer
|
643
-3.8%
49.36
31,738
USD
|
643
-3.8%
|
49.36
|
31,738
USD
|
|
2022-12-07 |
2022-12-05 |
S
Sale
|
Boerman Manja
Pres. BioModalities Division
Officer
|
780
-4.7%
51.70
40,326
USD
|
780
-4.7%
|
51.70
|
40,326
USD
|
|
2022-11-02 |
2022-10-31 |
S
Sale
|
Grippo Michael J
SVP, Strategy & Corp. Dev.
Officer
|
2,451
-12.1%
65.83
161,349
USD
|
2,451
-12.1%
|
65.83
|
161,349
USD
|
|
2022-10-12 |
2022-10-10 |
PS
Planned sale
|
Hawkeswood Thomas W
Pres. Pharma Prod Delivery Div
Officer
|
930
-14.8%
77.46
72,038
USD
|
930
-14.8%
|
77.46
|
72,038
USD
|
|
2022-09-02 |
2022-08-31 |
PS
Planned sale
|
Hopson Ricky
Pres. Clinical Dev Supply Div
Officer
|
2,216
-11.5%
89.59
198,531
USD
|
2,216
-11.5%
|
89.59
|
198,531
USD
|
|
2022-08-30 |
2022-08-26 |
PS
Planned sale
|
Gunther Scott
SVP, Quality & Reg. Affairs
Officer
|
1,639
-6.4%
104.07
170,571
USD
|
1,639
-6.4%
|
104.07
|
170,571
USD
|
|
2022-08-30 |
2022-08-26 |
PS
Planned sale
|
Riley Michael A.
Pres. Bio Product Delivery Div
Officer
|
2,491
-27.4%
104.07
259,238
USD
|
2,491
-27.4%
|
104.07
|
259,238
USD
|
|
2022-08-26 |
2022-08-25 |
S
Sale
|
Gargiulo Mario
SVP Global Ops Biologics
Officer
|
1,586
-20.0%
103.04
163,421
USD
|
1,586
-20.0%
|
103.04
|
163,421
USD
|
|
2022-08-26 |
2022-08-25 |
S
Sale
|
Grippo Michael J
SVP, Strategy & Corp. Dev.
Officer
|
1,670
-7.6%
103.04
172,077
USD
|
1,670
-7.6%
|
103.04
|
172,077
USD
|
|
2022-08-26 |
2022-08-25 |
S
Sale
|
Gunther Scott
SVP, Quality & Reg. Affairs
Officer
|
1,840
-6.7%
103.04
189,594
USD
|
1,840
-6.7%
|
103.04
|
189,594
USD
|
|
2022-08-26 |
2022-08-25 |
S
Sale
|
Castellano Thomas P
SVP, Chief Financial Officer
Officer
|
1,414
-6.6%
103.04
145,699
USD
|
1,414
-6.6%
|
103.04
|
145,699
USD
|
|
2022-08-26 |
2022-08-25 |
S
Sale
|
Pravda Ricardo
SVP & Chief HR Officer
Officer
|
1,747
-8.0%
103.04
180,011
USD
|
1,747
-8.0%
|
103.04
|
180,011
USD
|
|
2022-08-26 |
2022-08-25 |
S
Sale
|
Hunt Patricia
Pres. Consumer Health Div
Officer
|
339
-3.5%
103.04
34,931
USD
|
339
-3.5%
|
103.04
|
34,931
USD
|
|
2022-08-26 |
2022-08-25 |
S
Sale
|
Arnold Jonathan
SVP & Chief Commercial Ofcr
Officer
|
384
-0.7%
103.04
39,567
USD
|
384
-0.7%
|
103.04
|
39,567
USD
|
|
2022-08-26 |
2022-08-25 |
S
Sale
|
Gennadios Aristippos
Group Pres. Pharma & Consumer
Officer
|
1,645
-1.9%
103.04
169,501
USD
|
1,645
-1.9%
|
103.04
|
169,501
USD
|
|
2022-08-26 |
2022-08-25 |
S
Sale
|
Riley Michael A.
Pres. Bio Product Delivery Div
Officer
|
1,482
-14.0%
103.04
152,705
USD
|
1,482
-14.0%
|
103.04
|
152,705
USD
|
|
2022-08-26 |
2022-08-25 |
S
Sale
|
Maselli Alessandro
President & CEO
Executive Director
|
4,646
-10.1%
103.04
478,724
USD
|
4,646
-10.1%
|
103.04
|
478,724
USD
|
|
2022-08-26 |
2022-08-25 |
S
Sale
|
Boerman Manja
Pres. BioModalities Division
Officer
|
3,296
-16.5%
103.04
339,620
USD
|
3,296
-16.5%
|
103.04
|
339,620
USD
|
|
2022-08-26 |
2022-08-25 |
S
Sale
|
Chiminski John R
Executive Chair
Executive Director
|
38,934
-14.5%
103.04
4,011,759
USD
|
38,934
-14.5%
|
103.04
|
4,011,759
USD
|
|
2022-08-26 |
2022-08-25 |
S
Sale
|
Hopson Ricky
Pres. Clinical Dev Supply Div
Officer
|
1,517
-7.3%
103.04
156,312
USD
|
1,517
-7.3%
|
103.04
|
156,312
USD
|
|
2022-08-26 |
2022-08-25 |
S
Sale
|
Hawkeswood Thomas W
Pres. Pharma Prod Delivery Div
Officer
|
671
-9.6%
103.04
69,140
USD
|
671
-9.6%
|
103.04
|
69,140
USD
|
|
2022-08-26 |
2022-08-25 |
S
Sale
|
Carletti Lorenzo
SVP Global Ops Ph & Cons Hlth
Officer
|
1,033
-17.2%
103.04
106,440
USD
|
1,033
-17.2%
|
103.04
|
106,440
USD
|
|
2022-08-26 |
2022-08-25 |
S
Sale
|
Fasman Steven L
EVP & Chief Admin Officer
Officer
|
4,811
-7.2%
103.04
495,725
USD
|
4,811
-7.2%
|
103.04
|
495,725
USD
|
|
2022-08-26 |
2022-08-25 |
S
Sale
|
Schmidt Kay A
SVP, Enterprise Functions
Officer
|
1,321
-7.1%
103.04
136,116
USD
|
1,321
-7.1%
|
103.04
|
136,116
USD
|
|
2022-07-28 |
2022-07-27 |
PS
Planned sale
|
Gunther Scott
SVP, Quality & Reg. Affairs
Officer
|
394
-1.7%
107.67
42,422
USD
|
394
-1.7%
|
107.67
|
42,422
USD
|
|
2022-07-28 |
2022-07-27 |
PS
Planned sale
|
Hopson Ricky
Pres, Clinical Dev & Supply
Officer
|
591
-3.3%
107.67
63,633
USD
|
591
-3.3%
|
107.67
|
63,633
USD
|
|
2022-07-28 |
2022-07-27 |
PS
Planned sale
|
Grippo Michael J
SVP, Strategy & Corp. Dev.
Officer
|
388
-2.2%
107.67
41,776
USD
|
388
-2.2%
|
107.67
|
41,776
USD
|
|
2022-07-28 |
2022-07-26 |
S
Sale
|
Castellano Thomas P
SVP, Chief Financial Officer
Officer
|
347
-2.3%
106.90
37,094
USD
|
347
-2.3%
|
106.90
|
37,094
USD
|
|
2022-07-28 |
2022-07-26 |
S
Sale
|
Gunther Scott
SVP, Quality & Reg. Affairs
Officer
|
450
-2.0%
106.90
48,105
USD
|
450
-2.0%
|
106.90
|
48,105
USD
|
|
2022-07-28 |
2022-07-26 |
PS
Planned sale
|
Fasman Steven L
EVP & Chief Admin Officer
Officer
|
2,546
-4.5%
106.90
272,167
USD
|
2,546
-4.5%
|
106.90
|
272,167
USD
|
|
2022-07-28 |
2022-07-26 |
S
Sale
|
Gargiulo Mario
SVP Global Ops Biologics
Officer
|
969
-20.9%
106.90
103,586
USD
|
969
-20.9%
|
106.90
|
103,586
USD
|
|
2022-07-28 |
2022-07-26 |
S
Sale
|
Chiminski John R
Executive Chair
Executive Director
|
9,691
-6.8%
106.90
1,035,968
USD
|
9,691
-6.8%
|
106.90
|
1,035,968
USD
|
|
2022-07-28 |
2022-07-26 |
S
Sale
|
Gennadios Aristippos
Group Pres. Pharma & Consumer
Officer
|
403
-0.5%
106.90
43,081
USD
|
403
-0.5%
|
106.90
|
43,081
USD
|
|
2022-07-28 |
2022-07-26 |
S
Sale
|
Maselli Alessandro
President & CEO
Executive Director
|
816
-3.2%
106.90
87,230
USD
|
816
-3.2%
|
106.90
|
87,230
USD
|
|
2022-07-28 |
2022-07-26 |
PS
Planned sale
|
Hopson Ricky
Pres, Clinical Dev & Supply
Officer
|
312
-1.8%
106.90
33,353
USD
|
312
-1.8%
|
106.90
|
33,353
USD
|
|
2022-07-28 |
2022-07-26 |
S
Sale
|
Grippo Michael J
SVP, Strategy & Corp. Dev.
Officer
|
409
-2.5%
106.90
43,722
USD
|
409
-2.5%
|
106.90
|
43,722
USD
|
|
2022-07-28 |
2022-07-26 |
S
Sale
|
Arnold Jonathan
SVP & Chief Commercial Ofcr
Officer
|
94
-0.2%
106.90
10,049
USD
|
94
-0.2%
|
106.90
|
10,049
USD
|
|
2022-07-28 |
2022-07-26 |
S
Sale
|
Schmidt Kay A
SVP, Enterprise Functions
Officer
|
323
-2.3%
106.90
34,529
USD
|
323
-2.3%
|
106.90
|
34,529
USD
|
|
2022-07-28 |
2022-07-26 |
S
Sale
|
Carletti Lorenzo
SVP Global Ops Ph & Cons Hlth
Officer
|
631
-17.6%
106.90
67,454
USD
|
631
-17.6%
|
106.90
|
67,454
USD
|
|
2022-07-28 |
2022-07-26 |
S
Sale
|
Pravda Ricardo
SVP & Chief HR Officer
Officer
|
427
-2.7%
106.90
45,646
USD
|
427
-2.7%
|
106.90
|
45,646
USD
|
|